Arkolith/Insider Trading/TNYA/Form 4

Ali Faraz

Chief Executive Officer, DirectorTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Aug 16, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$28K
Net Open-Market Flow
-$28K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2024Sell(S)6K$2.89$17K192K
Aug 16, 2024Sell(S)4K$2.89$11K188K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-098234) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML